CEO Today - Healthcare Awards 2023

www.cdr-life.com Christian is a seasoned drug developer. He has worked in all phases of drug development within the areas of ophthalmology, oncology, autoimmunity, cardiovascular disease. Christian has led several global programs with new biologic entities including LME636 (Novartis) from the preclinical stage up through successful Phase 2 in two different ophthalmic diseases. He has also played lead roles in the clinical development of Rydapt (Approved in rare hematological disease) and brolucizumab (positive Phase 3 in retinal disease). Christian has served in Business Development & Licensing teams in Alcon and Novartis and was part of the senior management in ESBATech. He obtained his Ph.D. in biochemistry from ETH Zurich, Switzerland. In addition, he holds a Master of Science in Molecular Biology and in Chemistry from Roskilde University, Denmark. ABOUT CHRISTIAN LEISNER CEO Today Healthcare Awards 2023 - SWITZERLAND - - 34 -

RkJQdWJsaXNoZXIy Mjk3Mzkz